181 related articles for article (PubMed ID: 31243619)
1. Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas.
Rassi SZ; Ospina LH; Bochereau A; Samson Y; Perreault S; Saint-Amour D
Doc Ophthalmol; 2019 Oct; 139(2):137-149. PubMed ID: 31243619
[TBL] [Abstract][Full Text] [Related]
2. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas.
Trisciuzzi MT; Riccardi R; Piccardi M; Iarossi G; Buzzonetti L; Dickmann A; Colosimo C; Ruggiero A; Di Rocco C; Falsini B
Clin Neurophysiol; 2004 Jan; 115(1):217-26. PubMed ID: 14706491
[TBL] [Abstract][Full Text] [Related]
3. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pattern visual-evoked potentials to perimetry in the detection of visual loss in children with optic pathway gliomas.
Kelly JP; Weiss AH
J AAPOS; 2006 Aug; 10(4):298-306. PubMed ID: 16935227
[TBL] [Abstract][Full Text] [Related]
5. Visual-evoked potentials in the assessment of optic gliomas.
Ng YT; North KN
Pediatr Neurol; 2001 Jan; 24(1):44-8. PubMed ID: 11182280
[TBL] [Abstract][Full Text] [Related]
6. Visual electrophysiology in children with tumours affecting the visual pathway. Case reports.
Brecelj J; Stirn-Kranjc B; Skrbec M
Doc Ophthalmol; 2000 Sep; 101(2):125-54. PubMed ID: 11200546
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological monitoring in a patient with an optic nerve glioma.
Moradi P; Robson AG; Rose GE; Holder GE
Doc Ophthalmol; 2008 Sep; 117(2):171-4. PubMed ID: 18301934
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing optic pathway glioma and retinitis pigmentosa with visual field testing.
Weed MC; Almeida DR; Chin EK; Stone EM
Can J Ophthalmol; 2016 Jun; 51(3):e94-6. PubMed ID: 27316291
[No Abstract] [Full Text] [Related]
9. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
10. VEP testing and visual pathway gliomas: not quite ready for prime time.
Siatkowski RM
J AAPOS; 2006 Aug; 10(4):293-5. PubMed ID: 16935225
[No Abstract] [Full Text] [Related]
11. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.
Falsini B; Ziccardi L; Lazzareschi I; Ruggiero A; Placentino L; Dickmann A; Liotti L; Piccardi M; Balestrazzi E; Colosimo C; Di Rocco C; Riccardi R
J Neurooncol; 2008 May; 88(1):87-96. PubMed ID: 18246407
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial.
Falsini B; Chiaretti A; Rizzo D; Piccardi M; Ruggiero A; Manni L; Soligo M; Dickmann A; Federici M; Salerni A; Timelli L; Guglielmi G; Lazzareschi I; Caldarelli M; Galli-Resta L; Colosimo C; Riccardi R
Brain; 2016 Feb; 139(Pt 2):404-14. PubMed ID: 26767384
[TBL] [Abstract][Full Text] [Related]
13. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
[TBL] [Abstract][Full Text] [Related]
14. Visual Function, Brain Imaging, and Physiological Factors in Children With Asymmetric Nystagmus due to Chiasmal Gliomas.
Estrada M; Kelly JP; Wright J; Phillips JO; Weiss A
Pediatr Neurol; 2019 Aug; 97():30-37. PubMed ID: 31113715
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
16. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
[TBL] [Abstract][Full Text] [Related]
17. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF
Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799
[TBL] [Abstract][Full Text] [Related]
18. Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials.
North K; Cochineas C; Tang E; Fagan E
Pediatr Neurol; 1994 Mar; 10(2):117-23. PubMed ID: 8024659
[TBL] [Abstract][Full Text] [Related]
19. Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab.
Avery RA; Hwang EI; Jakacki RI; Packer RJ
JAMA Ophthalmol; 2014 Jan; 132(1):111-4. PubMed ID: 24232489
[TBL] [Abstract][Full Text] [Related]
20. Visual field fluctuations correlating with the menstrual cycle in a patient with optic pathway glioma.
Jacobson A; Leonard M; Robertson P; Bohnsack BL
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
